- Demographic data, complications, cause of death, and mortality/year.
| Variables | n (%) |
|---|---|
| Gender | |
| Male | 72 (59.0) |
| Female | 50 (41.0) |
| Age groups | |
| 0.5-14 years | 40 (32.8) |
| 15-35 years | 19 (15.6) |
| 36-53 years | 16 (13.1) |
| 54-71 years | 45 (36.9) |
| 72-89 years | 2 (1.6) |
| Graft appearance | |
| Homogeneous | 82 (67.2) |
| Heterogeneous | 15 (12.3) |
| Hyperechoic | 25 (20.5) |
| Graft types | |
| Deceased | 10 (8.1) |
| Living non-related doner | 17 (13.9) |
| Living related doner | 95 (77.8) |
| Adults - pediatrics | |
| Adults | 82 (67.2) |
| Pediatrics | 40 (32.8) |
| General complications | |
| Acute cellular rejection | 2 (1.6) |
| Bile leak | 9 (7.4) |
| Biliary dilation | 15 (12.3) |
| Chronic rejection | 1 (0.8) |
| Collection | 69 (56.6) |
| Malignancy | 1 (0.8) |
| None | 16 (13.1) |
| Vascular | 9 (7.4) |
| Type of VCs | |
| Hepatic artery stenosis | 1 (0.8) |
| Hepatic artery thrombosis | 1 (0.8) |
| IVC thrombosis | 1 (0.8) |
| None | 113 (92.6) |
| Portal vein thrombosis | 5 (4.1) |
| Portal vein thrombosis with hepatic artery stenosis | 1 (0.8) |
| Causes of death | |
| Cardiopulmonary | 4 (19.0) |
| Infection | 3 (14.3) |
| Other causes | 6 (28.6) |
| Primary graft non-function | 1 (4.8) |
| Renal impairment | 1 (4.8) |
| Sepsis | 4 (19.0) |
| Septic shock | 1 (4.8) |
| VC | 1 (4.8) |
| Early post operative mortality | |
| 2016 | 1 (8.3) |
| 2017 | 7 (53.8) |
| 2018 | 3 (11.1) |
| 2019 | 5 (16.7) |
| 2020 | 2 (14.3) |
| 2021 | 3 (14.3) |
| 2022 | 0 (0.0) |
Values are presented as numbers and percentages (%).
VC: vascular complication, IVC: inferior vena cava